Latest

The most recent stories of CVS Health's legal troubles, settlements, and controversies

CVS NEWS

FEATURED STORIES

RECENT NEWS

Fraud 2025

CVS Pays $37.76 Million to Settle Insulin Pen Dispensing Allegations

U.S. Attorney, SDNY • 2025

Federal prosecutors announced a $37.76 million settlement with CVS over allegations tied to the dispensing of insulin pens.

The government alleged CVS submitted claims involving improperly dispensed insulin pen prescriptions and reached a major settlement to resolve the matter.

Read full article
Corporate 2025

FTC Releases Second Report Criticizing Pharmacy Benefit Managers

Healthcare Dive • 2025

A second FTC report scrutinized major pharmacy benefit managers, including CVS Caremark, over their role in drug pricing and market concentration.

Regulators raised concerns that large PBMs may be increasing costs and distorting competition across the prescription drug supply chain.

Read full article
Corporate 2024

CVS Pharmacy Technicians Strike Over Unfair Labor Practices

Forbes • 2024

CVS pharmacy technicians joined picket lines amid complaints over working conditions, labor practices, and chronic staffing pressures.

Workers and labor advocates argued that pharmacy staff were under strain and that company practices were contributing to unsafe and unsustainable conditions.

Read full article
Safety 2024

Ohio Board of Pharmacy Reaches Settlement with CVS Over 27 Cases

Ohio Board of Pharmacy • 2024

Ohio regulators announced a settlement with CVS stores to resolve multiple pharmacy enforcement and compliance cases.

The agreement covered 27 cases involving CVS pharmacy operations in Ohio and outlined corrective action and penalties.

Read full article
Fraud 2023

CVS Caremark Agrees to Pay $95.4M to Resolve Medicare Allegations

U.S. Department of Justice • 2023

The Justice Department said CVS Caremark agreed to pay $95.4 million to resolve False Claims Act allegations involving Medicare.

Federal officials alleged the company submitted or caused false claims related to Medicare beneficiaries and prescription drug administration.

Read full article
Opioid 2021

Jury Finds CVS and Other Pharmacy Chains Liable in Ohio Opioid Trial

Reuters • 2021

A federal jury found CVS and other major pharmacy chains liable in the first trial over the U.S. opioid epidemic.

The verdict marked a major moment in opioid litigation, with jurors finding chain pharmacies contributed to a public nuisance in Ohio counties.

Read full article
Opioid 2021

CVS Announces $5 Billion Opioid Settlement Framework

Reuters • 2021

CVS announced a multibillion-dollar framework to settle opioid-related claims brought by states and local governments.

The proposed agreement was part of broader efforts to resolve thousands of lawsuits over the role of prescription drug distribution in the opioid crisis.

Read full article
Discrimination 2021

Former CVS Detectives Allege Racial Profiling of Shoppers

Associated Press • 2021

Two former CVS security employees alleged they were directed to target Black and Latino shoppers for surveillance.

The lawsuit added to broader concerns about discrimination and retail surveillance practices affecting customers of color.

Read full article
Medication Errors 2020

Pharmacists Across the U.S. Say They're Overworked and Errors Are Increasing

The New York Times • 2020

Pharmacists described rising pressure, understaffing, and increasing risk of medication mistakes in major retail chains including CVS.

The reporting highlighted how difficult pharmacy working conditions can affect both staff wellbeing and patient safety.

Read full article
Privacy 2019

CVS-Owned Aetna Exposes Thousands of HIV Patients in Mail Error

NBC News • 2019

Aetna faced backlash after a mailer design allegedly exposed the HIV status of thousands of patients through transparent envelope windows.

The incident raised major privacy concerns and drew attention to the risks of mishandling sensitive health information.

Read full article
Discrimination 2018

CVS Ends Practice of Locking Up Black Hair Products

CNN • 2018

CVS said it would stop locking up beauty products aimed at Black customers after criticism over discriminatory retail practices.

The company changed course after customers and advocates argued the policy unfairly stigmatized products marketed to Black consumers.

Read full article

Want to take action against CVS's anti-competitive practices?